Hille, E.T.

study tamoxifen exemestane cancer infant birth patient hearing loss hearing breast treatment factor problem breast cancer preterm weight trial group risk factors 5 years analysis outcome netherland children population education expression score receptor birth weight 19 years bene fit table university adjuvant tumor result health ventilation ≥5 days pediatrics analyses birth asphyxia postmenopausal women postmenopausal therapy growth status signi hospital preterm infants arch dis child birth weight infants swets blackwell 76157563 center pgr expression grade cohort point article age <30 weeks dutch event survivor effect screening imputation p fizer age infants intelligence handicap society american follow-up oncology oncol child neurosensory oncology information downloaded john m.s participation